Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan.

Japanese journal of infectious diseases - 1 May 2007

Fujisaki Seiichiro, Fujisaki Saeko, Ibe Shiro, Asagi Tsukasa, Itoh Toshihiro, Yoshida Shigeru, Koike Takao, Oie Masayasu, Konda Makiko, Sadamasu Kenji, Nagashima Mami, Gatanaga Hiroyuki, Matsuda Masakazu, Ueda Mikio, Masakane Aki, Hata Mami, Mizogami Yasushi, Mori Haruyo, Minami Rumi, Okada Kiyomi, Watanabe Kanako, Shirasaka Takuma, Oka Shinichi, Sugiura Wataru, Kaneda Tsuguhiro

Abstract excerpt

Highly active antiretroviral therapy (HAART) can suppress human immunodeficiency virus type 1 (HIV-1) replication and plasma HIV-1 to below detectable levels. However, HAART becomes ineffective when drug-resistant viruses emerge during HAART. Monitoring drug-resistance mutations in viruses is nec...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Laboratories

Share to Quality Control

Share to Specimen Handling

Source

Identifiers

PMID: 17515643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17515643-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan.PMID 17515643Read ↗

[Evaluation of the consistency of three methods for testing HIV-1 genotype drug resistance].Semantic proximity Read ↗

Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and usefulness of genotype testing.Semantic proximity Read ↗

External Quality Assessment Scheme for HIV-1 Drug-Resistance Genotyping in Thailand.Semantic proximity Read ↗

Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.Semantic proximity Read ↗

Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan.Semantic proximity Read ↗

Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007–2010Semantic proximity Read ↗

[The impact of resistance testing of HIV-1 to the HIV clinical setting in Japan].Semantic proximity Read ↗

[The study of an in-house method for drug resistance genotyping testing on HIV-1 strains prevailing in China].Semantic proximity Read ↗

[The outer quality control of identification of mutations of HIV drug resistance to anti-retrovirus preparations: the results of "HIV resistance-2009" program].Semantic proximity Read ↗

TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesSemantic proximity Read ↗

Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan.Semantic proximity Read ↗

Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.